Cargando…

Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations

BACKGROUND: The majority (>95%) of new HIV infection occurs in resource-limited settings, and Cameroon is still experiencing a generalized epidemic with ~122,638 patients receiving antiretroviral therapy (ART). A detrimental outcome in scaling-up ART is the emergence HIV drug resistance (HIVDR),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fokam, Joseph, Elat, Jean-Bosco N., Billong, Serge C., Kembou, Etienne, Nkwescheu, Armand S., Obam, Nicolas M., Essiane, André, Torimiro, Judith N., Ekanmian, Gatien K., Ndjolo, Alexis, Shiro, Koulla S., Bissek, Anne C. Z-K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471113/ https://www.ncbi.nlm.nih.gov/pubmed/26083364 http://dx.doi.org/10.1371/journal.pone.0129210

Ejemplares similares

Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010
por: Billong, Serge C., et al.
Publicado: (2012)

Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008–2010: lessons and challenges for low-resource settings
por: Fokam, Joseph, et al.
Publicado: (2013)

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance
por: Billong, Serge C., et al.
Publicado: (2013)

Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling
por: Billong, Serge Clotaire, et al.
Publicado: (2016)

Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure
por: Billong, Serge C., et al.
Publicado: (2017)

The declining trend of HIV-Infection among pregnant women in Cameroon infers an epidemic decline in the general population
por: Billong, Serge-Clotaire, et al.
Publicado: (2020)

Mapping and size estimates of female sex workers in Cameroon: Toward informed policy for design and implementation in the national HIV program
por: Billong, Serge C., et al.
Publicado: (2019)

Profil national des indicateurs d’alerte précoce de la pharmaco-résistance du VIH au Cameroun
por: Billong, Serge Clotaire, et al.
Publicado: (2020)

Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis
por: Anoubissi, Jean de Dieu, et al.
Publicado: (2019)

Snakebite in bedroom kills a physician in Cameroon: a case report
por: Nkwescheu, Armand, et al.
Publicado: (2016)

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020)

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”
por: Fokam, Joseph, et al.
Publicado: (2019)

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013)
por: Bigna, Jean Joel R., et al.
Publicado: (2015)

Distribution épidémiologique de l'infection à VIH chez les femmes enceintes dans les dix régions du Cameroun et implications stratégiques pour les programmes de prévention
por: Billong, Serge-Clotaire, et al.
Publicado: (2015)

Current practice of epidemiology in Africa: highlights of the 3(rd) conference of the African epidemiological association and 1(st) conference of the Cameroon society of epidemiology, Yaoundé, Cameroon, 2014
por: Nkwescheu, Armand Seraphin, et al.
Publicado: (2015)

Prevalence and risk factors to HIV-infection amongst health care workers within public and private health facilities in Cameroon
por: Domkam, Irénée Kammogne, et al.
Publicado: (2018)

Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis
por: Kengne-Nde, Cyprien, et al.
Publicado: (2020)

Correlates of prior HIV testing among men who have sex with men in Cameroon: a cross-sectional analysis
por: Park, Ju Nyeong, et al.
Publicado: (2014)

Predictors of early childhood HIV testing among children of sex workers living with HIV in Cameroon
por: Rao, Amrita, et al.
Publicado: (2019)

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
por: Fokam, Joseph, et al.
Publicado: (2019)

Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon
por: Fokam, Joseph, et al.
Publicado: (2017)

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

High snakebite underreporting rate in the Centre Region of Cameroon: an observational study
por: Tchoffo, Désiré, et al.
Publicado: (2019)

Characteristics of patients co-infected with HIV at the time of inpatient tuberculosis treatment initiation in Yaoundé, Cameroon: a tertiary care hospital-based cross-sectional study
por: Agbor, Ako A, et al.
Publicado: (2015)

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006–2013)
por: Agbor, Ako A., et al.
Publicado: (2014)

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Features of human scabies in resource-limited settings: the Cameroon case
por: Kouotou, Emmanuel Armand, et al.
Publicado: (2015)

Community-based audits of snake envenomations in a resource-challenged setting of Cameroon: case series
por: Tianyi, Frank-Leonel, et al.
Publicado: (2018)

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
por: Takou, Desire, et al.
Publicado: (2019)

Dealing with snakebite in rural Cameroon: A qualitative investigation among victims and traditional healers
por: Chuat, Manon, et al.
Publicado: (2021)

Snakebite epidemiology and health-seeking behavior in Akonolinga health district, Cameroon: Cross-sectional study
por: Alcoba, Gabriel, et al.
Publicado: (2020)

Knowledge, attitudes and practices of the medical personnel regarding atopic dermatitis in Yaoundé, Cameroon
por: Kouotou, Emmanuel Armand, et al.
Publicado: (2017)

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
por: Fokam, Joseph, et al.
Publicado: (2023)

Regional vulnerability for COVID-19 in Cameroon
por: Judson, Seth David, et al.
Publicado: (2020)

Factors associated with non-adherence to antiretroviral therapy among HIV-infected adolescents aged 15-19 years: a snapshot from the Mother and Child Center in Yaounde, Cameroon
por: Lantche, Martial Wandji, et al.
Publicado: (2021)

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
por: Ndawinz, Jacques DA, et al.
Publicado: (2015)

Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon?
por: Fomulu, Nelson J, et al.
Publicado: (2013)

Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO)
por: Dzudie, Anastase, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5o65jkg92d2tns22thnhvcfsgu